Chris's Feed
Sep 25, 2014
via Breakingviews

Tesco chairman should step aside

Photo

By Chris Hughes

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Tesco’s chairman should step aside. Richard Broadbent will struggle to restore market confidence in the troubled UK supermarket group, and to convince investors the board is on top of matters. This week’s accounting scandal has compounded existing concerns about his period at the helm. The priority should be an orderly handover to the right successor as soon as possible.

Sep 22, 2014
via Breakingviews

Tesco chairman approaches his sell-by date

Photo

By Chris Hughes

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Tesco’s latest crisis has put Richard Broadbent in the last chance saloon. The chairman of the UK retailer is ultimately accountable for any failures in the UK grocer’s governance. That includes any that lie behind the 250 million pound hole in the accounts, revealed on Monday.

Jul 18, 2014
via Breakingviews

UK banks have much to fear from latest probe

Photo

By Chris Hughes

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

The latest competition review of UK banking should aim to be the last. An antitrust probe in 2000 led to limited price controls after concluding that British lenders made excess profit. There were two more big investigations after the financial crisis. Yet concerns about market inefficiencies persist. That suggests the Competition and Markets Authority should do something radical this time.

May 27, 2014
via Breakingviews

Failed bid would leave Astra under pressure

Photo

By Chris Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

The likely failure of U.S. drugmaker Pfizer’s $119 billion bid for AstraZeneca, which was due to lapse on May 26, would leave the frustrated buyer no worse off. But the target has much to prove. Some of its shareholders welcomed a possible takeover – and could again.

May 21, 2014
via Breakingviews

Astra-Pfizer needs a fresh start later in the year

Photo

By Chris Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

AstraZeneca should not reengage with Pfizer in the dying days of the takeover timetable. Talks now would either be fruitless or delay a proper restart later.

May 20, 2014
via Breakingviews

Loophole offers Pfizer risky way back into AZ deal

Photo

By Chris Hughes

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Pfizer has a risky way back into a deal with AstraZeneca. An apparent loophole in Britain’s takeover code means the U.S. pharma group could offer the 58.85 pounds-a-share demanded by Astra for a recommendation, even after declaring that the earlier 55 pounds-a-share pitch was “final.”

May 15, 2014
via Breakingviews

Where should AstraZeneca shares be trading?

Photo

By Chris Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Investors are putting a lot of faith in Pfizer succeeding in its $100 billion-plus quest to acquire UK pharmaceuticals rival AstraZeneca. The right price for the target’s share price can be seen as the weighted average of two possible outcomes – a sale to Pfizer or a standalone future. A new Breakingviews calculator shows why the market seems to think a transaction will probably happen.

Apr 3, 2014
via Breakingviews

Blythe Masters could chair Glencore

Photo

By Christopher Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Blythe Masters’ exit from JPMorgan with the sale of its physical commodities business could solve Glencore’s longstanding search for a chairman. The brains behind the credit default swap has the expertise to join the trading house’s board, whose all-male roll makes it an anachronism in the FTSE-100. But there is one big obstacle to her leading this or any board – she has never run a company before.

Apr 3, 2014
via Breakingviews

Blythe Masters could chair Glencore

Photo

By Christopher Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

Blythe Masters’ exit from JPMorgan with the sale of its physical commodities business could solve Glencore’s longstanding search for a chairman. The brains behind the credit default swap has the expertise to join the trading house’s board, whose all-male roll makes it an anachronism in the FTSE-100. But there is one big obstacle to her leading this or any board – she has never run a company before.

Jan 24, 2014
via Breakingviews

The “R” word becomes taboo for global elite

Photo

By Chris Hughes and Rob Cox

The authors are Reuters Breakingviews columnists. The opinions expressed are their own.

Spare a thought for the business and financial elite as they slide along the icy byways of the World Economic Forum in Davos. Life is undeniably picking up for them and it would be nice to say so. But the economic recovery has its winners and losers, and it looks bad to be a beneficiary at a conference whose overarching theme is “inclusive growth.”

    • About Chris

      "Chris Hughes is EMEA Editor of Reuters Breakingviews. Chris started his career as a researcher in BBC Television’s documentaries department and then became a financial journalist. He was previously Investment Banking Correspondent and Senior Corporate Reporter at the Financial Times, Financial Editor of The Independent and a companies writer at the Investors Chronicle. Chris has also worked at communications consultancy Financial Dynamics (now FTI), as an Associate Partner."
    • Follow Chris